Sepia, Sage, Anchor sell 2.63m Corona Remedies shares under SAST
- Sepia Investments, Sage Investment Trust, and Anchor Partners sold 2.63 million shares
- Sales occurred via open market on NSE on September 10, 2026
- Disclosure filed under SEBI SAST Regulations 29(2)
- Sepia's stake reduced from 12.68% to 8.62%
- Sellers are identified as persons acting in concert
*this image is generated using AI for illustrative purposes only.
Sepia Investments Limited, Sage Investment Trust, and Anchor Partners disposed of a combined 26,29,880 equity shares of Corona Remedies Limited through open market sales on the National Stock Exchange of India Limited (NSE).
The transaction, executed on September 10, 2026, was disclosed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (SAST). The sellers are persons acting in concert. The formal disclosure letter was dated September 18, 2026, and signed by Panir Pushpom Soobiah for Sepia Investments Limited, and Ashley Menezes for both Sage Investment Trust and Anchor Partners.
Disposal Breakdown
Sepia Investments Limited led the exit, offloading 24,85,476 shares, representing 4.06% of the total voting capital. Sage Investment Trust sold 51,641 shares (0.08%), while Anchor Partners disposed of 92,763 shares (0.15%).
| Seller | Shares Sold | % of Voting Capital |
|---|---|---|
| Sepia Investments Limited | 24,85,476 | 4.06% |
| Sage Investment Trust | 51,641 | 0.08% |
| Anchor Partners | 92,763 | 0.15% |
Post-Transaction Holdings
Following the sale, Sepia Investments’ holding fell from 12.68% to 8.62%. Sage Investment Trust’s stake reduced from 0.26% to 0.18%, and Anchor Partners’ holding declined from 0.47% to 0.32%.
| Entity | Pre-Sale Holding | Post-Sale Holding |
|---|---|---|
| Sepia Investments Limited | 77,55,786 (12.68%) | 52,70,310 (8.62%) |
| Sage Investment Trust | 1,61,400 (0.26%) | 1,09,759 (0.18%) |
| Anchor Partners | 2,89,992 (0.47%) | 1,97,229 (0.32%) |
Corona Remedies Limited has an equity share capital of ₹61,16,00,880, divided into 61,16,008 equity shares of face value ₹10 each. The total diluted share capital remains unchanged at this level.
Historical Stock Returns for Corona Remedies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.48% | +0.05% | +4.20% | +41.05% | +53.07% | +53.07% |
How might the significant reduction in Sepia Investments' stake from 12.68% to 8.62% impact Corona Remedies' corporate governance and board dynamics?
Could this coordinated exit by persons acting in concert signal broader institutional concerns regarding Corona Remedies' near-term growth prospects or valuation?
What are the likely implications for Corona Remedies' stock price volatility in the immediate weeks following this large open market disposal?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
